Pharmacological profile of novel cyclic analogs of 2-amino-7-phosphonoheptanoic acid.
Pharmacological profile of novel cyclic analogs of 2-amino-7-phosphonoheptanoic acid.
复制标题
2-氨基-7-膦酰庚酸新型环状类似物的药理学概况。
DOI:
10.1016/b978-0-444-89710-7.50033-1
复制
发表时间:
1992
期刊:
影响因子:
--
通讯作者:
Patch,R
中科院分区:
文献类型:
--
作者:
Ferkany,JW;Kyle,DJ;Ellenberger,WP;Narayanan,BA;Ellenberger,SR;Hudkins,R;Guzewska,ME;Rzeszotarski,WJ;Conti,L;Patch,R
Excitatory amino acids (EAA) are among the most prevalent and widespread neurotransmitters in the mammalian brain. Consistent with a function as neu-rotransmitters or neuromodulators, multiple receptors for FAAs have been identified. Originally classified according to agonist pharmacology, these were divided into kainic acid (KA), quisqualic acid, and N-methyl-D-aspartatic acid (NMDA) recognition sites (30). Although this classification remains valid, more recent work indicates that FAA receptors and EAA neurotransmission are even more subtle and complex than first suggested. For example, beyond the three ionotropic recognition sites mentioned above, meta-botropic receptors have been identified that are sensitive to quisqualate and directly linked to inositol phosphate turnover or intracellular Ca mobilization (19, 25, 27). Furthermore, the NMDA receptor is now believed to be a complex molecular entity regulated by divalent cations as well as is the amino acid glycine. The latter may function as either a positive modulator, or as a cotransmitter at the receptor com plex (9-11).The growing interest in EAA mediated transmission has led to an increasing awareness of the role EAAs play in physiological and pathological function of the central nervous system. Because of the early availability of agonists and antagonists, the under standing of NMDA receptor activity is most advanced. Although agonists such as NMDA, the endogenous tryptophan metabolite, quinolinate (QUIN).